Advances on radiomics in adrenal adenoma

doi:10.3969/j.issn.1674-490X.2022.03.005

Abstract

Abstract: Adrenal adenoma is a common tumor in clinical practices. At present, initial progress has been made in the identification of adrenal benign and malignant tumors, functional adrenal adenoma subtypes, lipid adenoma and pheochromocytoma. Studies on adrenal adenoma are mainly carried out through texture analysis and histogram analysis, which can effectively evaluate tumor atypia and provide effective help in clinical decision-making.In addition, the normogram model combining clinical features and imaging features has a good identification effect for functional adrenal adenoma subtypes. The purpose of this article is to review the current status, problems and prospects of imaging in the diagnosis and differential diagnosis of adrenal adenoma, and the prediction, monitoring and prognosis of treatment strategies.

Key words: adrenal adenoma, aldosterone adenoma, cortisol adenoma, precision medicine, radiomics

CLC Number:

R445

WU Chunmei, YIN Xiaoping. Advances on radiomics in adrenal adenoma[J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(3): 29-34.

References

[1] SONG J H, CHAUDHRY F S, MAYO-SMITH W W. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy[J].AJR Am J Roentgenol, 2008, 190(5):1163-1168. DOI: 10.2214/AJR.07.2799.
[2] LOW G, SAHI K. Clinical and imaging overview of functional adrenal neoplasms[J]. Int J Urol, 2012, 19(8):697-708. DOI: 10.1111/j.1442-2042.2012.03014.x.
[3] 王文红,白人驹,孙浩然,等.良、恶性乏脂质性肾上腺肿瘤的动态MRI检查[J].医学影像学杂志, 2009, 19(11): 1426-1429. DOI: 10.3969/j.issn.1006-9011.2009.11.020.
[4] LAMBIN P, LEIJENAAR R T H, DEIST T M, et al. Radiomics: the bridge between medical imaging and personalized medicine[J]. Nat Rev Clin Oncol, 2017, 14(12): 749-762. DOI: 10.1038/nrclinonc.2017.141.
[5] 刘再毅,梁长虹.影像组学研究浅见[J].影像诊断与介入放射学, 2017, 26(3): 253-254. DOI: 10.3969/j.issn.1005-8001.2017.00.019.
[6] LAMBIN P, RIOS-VELAZQUEZ E, LEIJENAAR R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48(4): 441-446. DOI: 10.1016/j.ejca.2011.11.036.
[7] FEDOROV A, BEICHEL R, KALPATHY-CRAMER J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network[J]. Magn Reson Imaging, 2012, 30(9): 1323-1341. DOI: 10.1016/j.mri.2012.05.001.
[8] WOLF I, VETTER M, WEGNER I, et al. The medical imaging interaction toolkit[J]. Med Image Anal, 2005, 9(6): 594-604. DOI: 10.1016/j.media.2005.04.005.
[9] 李双双,侯震,刘娟,等.影像组学分析与建模工具综述[J].中国医学物理学杂志, 2018, 35(9): 1043-1049. DOI: 10.3969/j.issn.1005-202X.2018.09.010.
[10] DINNES J, BANCOS I, FERRANTE DIRUFFANO L, et al. Management of endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis[J]. Eur J Endocrinol, 2016, 175(2): R51-R64. DOI: 10.1530/EJE-16-0461.
[11] ELBANAN M G, JAVADI S, GANESHAN D, et al. Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics[J]. Abdom Radiol(NY), 2020, 45(4): 905-916. DOI: 10.1007/s00261-019-02215-9.
[12] 闫海波.双源CT在鉴别诊断肾上腺乏脂肪腺瘤、小转移瘤中的应用价值[J].中国CT和MRI杂志, 2020, 18(2): 106-108, 112. DOI: 10.3969/j.issn.1672-5131.2020.02.032.
[13] YI X P, GUAN X, CHEN C, et al. Adrenal incidentaloma: machine learning-based quantitative texture analysis of unenhanced CT can effectively differentiate sPHEO from lipid-poor adrenal adenoma[J]. J Cancer, 2018, 9(19): 3577-3582. DOI: 10.7150/jca.26356.
[14] LOTFI C F P, KREMER J L, DOS SANTOS PASSAIA B, et al. The human adrenal cortex: growth control and disorders[J]. Clinics(Sao Paulo), 2018, 73(Suppl 1): e473s. DOI: 10.6061/clinics/2018/e473s.
[15] KLINE G, HOLMES D T. Adrenal venous sampling for primaryaldosteronism: laboratory medicine best practice[J]. Clin Pathol, 2017, 70: 911-16. DOI: 10.1136/jclinpath-2017-204423.
[16] ZHENG Y N, LIU X, ZHONG Y, et al. A preliminary study for distinguish hormone-secreting functional adrenocortical adenoma subtypes using multiparametric CT radiomics-based machine learning model and nomogram[J]. Front Oncol, 2020, 10: 570502. DOI: 10.3389/fonc.2020.570502.
[17] BAO M Y, ZHANG L H, HU Y Q. Novel gene signatures for prognosis prediction in ovarian cancer[J]. J Cell Mol Med, 2020, 24(17): 9972-9984. DOI: 10.1111/jcmm.15601.
[18] HE K, ZHANG Z T, WANG Z H, et al. A clinical-radiomic nomogram based on unenhanced computed tomography for predicting the risk of aldosterone-producing adenoma[J]. Front Oncol, 2021, 11: 634879. DOI: 10.3389/fonc.2021.634879.
[19] STANZIONE A, CUOCOLO R, VERDE F, et al. Handcrafted MRI radiomics and machine learning: classification of indeterminate solid adrenal lesions[J]. Magn Reson Imaging, 2021, 79: 52-58. DOI: 10.1016/j.mri.2021.03.009.
[20] TORRESAN F, CRIMÌ F, CECCATO F, et al. Radiomics: a new tool to differentiate adrenocortical adenoma from carcinoma[J]. BJS Open, 2021, 5(1): zraa061. DOI: 10.1093/bjsopen/zraa061.
[21] HO L M, SAMEI E, MAZUROWSKI M A, et al. Can texture analysis be used to distinguish benign from malignant adrenal nodules on unenhanced CT, contrast-enhanced CT, or in-phase and opposed-phase MRI?[J].AJR Am J Roentgenol, 2019, 212(3): 554-561. DOI: 10.2214/AJR.18.20097.
[22] ELMOHR M M, FUENTES D, HABRA M A, et al. Machine learning-based texture analysis for differentiation of large adrenal cortical tumours on CT[J]. Clin Radiol, 2019, 74(10): 818.e1-818.e7. DOI: 10.1016/j.crad.2019.06.021.
[23] ROMEO V, MAUREA S, CUOCOLO R, et al. Characterization of adrenal lesions on unenhanced MRI usingtexture analysis: a machine-learning approach[J].Magn Reson Imaging, 2018, 48(1): 198-204. DOI: 10.1002/jmri.25954.
[24] SHI B, ZHANG G M, XU M, et al. Distinguishing metastases from benign adrenal masses:whatcan CT texture analysis do?[J]. Acta Radiol, 2019, 60(11): 1553-1561. DOI: 10.1177/0284185119830292.
[25] ANSQUER C, DRUI D, MIRALLIE E, et al. Usefulness of FDG-PET/CT-based radiomics for the characterization and genetic orientation of pheochromocytomas before surgery[J]. Cancers(Basel), 2020, 12(9): 2424. DOI: 10.3390/cancers12092424.
[26] ZWANENBURG A, VALLIÈRES M, ABDALAH M A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping[J]. Radiology, 2020, 295(2): 328-338. DOI: 10.1148/radiol.2020191145.
[27] YI X P, GUAN X, ZHANG Y M, et al. Radiomics improves efficiency for differentiating subclinical pheochromocytoma from lipid-poor adenoma: a predictive, preventive and personalized medical approach in adrenal incidentalomas[J]. EPMA J, 2018, 9(4): 421-429. DOI: 10.1007/s13167-018-0149-3.
[28] GOLUBNITSCHAJA O, BABAN B, BONIOLO G, et al. Medicine in the early twenty-first century: paradigm and anticipation:EPMA position paper 2016[J]. EPMA J, 2016, 7(1): 23. DOI: 10.1186/s13167-016-0072-4.
[29] ALIC L, NIESSEN W J, VEENLAND J F. Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review[J]. PLoS One, 2014, 9(10): e110300. DOI: 10.1371/journal.pone.0110300.
[30] SALA E, MEMA E, HIMOTO Y, et al. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging[J]. Clin Radiol, 2017, 72(1): 3-10. DOI: 10.1016/j.crad.2016.09.013.
[31] LAMBIN P, VANSTIPHOUT R G, STARMANS M H,et al. Predicting outcomes in radiation oncology-multifactorial decision support systems[J]. Nat Rev Clin Oncol, 2013, 10(1):27-40. DOI: 10.1038/nrclinonc.2012.196.